Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|June 1, 1991
Resilience and human adaptability: who rises above adversity? 1990 Eleanor Clarke Slagle LectureS B Fine
Annals of Biomedical Engineering|January 1, 1984
Dual energy CT scanning for analysis of brain damage due to X-irradiationL B Russell, J R Fike, C E Cann, et al.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|April 1, 1987
Developing a Role Activity Performance ScaleM A Good-Ellis, S B Fine, J H Spencer, et al.
Military Medicine|July 22, 1999
Use of a critical pathway to move laparoscopic cholecystectomy to the ambulatory surgery arenaJ M Irizarry, M H Graham, P R Cordts
Expert Review of Clinical Immunology|March 10, 2017
Commonality of the IL-4/IL-13 pathway in atopic diseasesNamita A Gandhi, Gianluca Pirozzi, Neil M H Graham
Hospital & Community Psychiatry|March 1, 1988
An interdisciplinary psychoeducation program for schizophrenic patients and their families in an acute care settingL Greenberg, S B Fine, C Cohen, et al.
Arthritis Research & Therapy|October 8, 2016
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITYAnita Boyapati, Jérôme Msihid, Stefano Fiore, et al.
RMD Open|March 21, 2018
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET studyCem Gabay, Jérôme Msihid, Moshe Zilberstein, et al.
Arthritis Research & Therapy|March 22, 2019
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in JapanYoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, et al.
Arthritis Research & Therapy|April 18, 2019
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in JapanYoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, et al.
Pageof 8